Dual-Contrast Dynamic MRI-DOT for Small Animal Imaging

• Published in: Technology in cancer research & treatment 2010-02, Vol.9 (1), p.61-69
• Main Authors: Thayer, David, Unlu, Mehmet Burcin, Lin, Yuting, Yan, Kevin, Nalcioglu, Orhan, Gulsen, Gultekin
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - pathology; Animals; Contrast Media; Female; Gadolinium DTPA; Indocyanine Green; Magnetic Resonance Imaging - methods; Mammary Neoplasms, Animal - pathology; Rats; Rats, Inbred F344; Tomography, Optical - methods
• ISSN: 1533-0346; 1533-0338
• DOI: 10.1177/153303461000900107

In this paper we present first-of-its-kind spatially resolved enhancement kinetics of optical and magnetic resonance (MR) agents obtained by a combined MR and Diffuse Optical Tomography (MR-DOT) animal imaging system. A unique MR compatible fiber optic interface allows co-registration of MR and DOT data in space and time. High temporal resolution of the hybrid system permits acquisition of data in dynamic mode. Rats bearing a R3230 AC breast cancer tumor model are used for in vivo studies. Thirty-two optical and thirty MR images are acquired during a single imaging session that lasts nearly ten minutes. Both optical, indocyanine green (ICG), and MR contrast agents, gadolinium-DTPA (Gd-DTPA), are injected simultaneously after the acquisition of several baseline frames. Contrast enhancement time curves obtained by MR and DOT systems both indicate higher average enhancement in tumor regions, up to ten-fold for MRI and 3-fold for DOT, compared to close by non-tumor regions. This feasibility study is the first step towards clinical translation of this hybrid imaging platform. The ultimate aim is to use the enhancement kinetics of the optical agent ICG, which binds to plasma proteins, as complementary information to the kinetics of the MR agent Gd-DTPA, a small molecular agent that does not bind to plasma proteins, to better differentiate benign and malignant lesions.